Ignite Creation Date:
2025-12-24 @ 12:17 PM
Ignite Modification Date:
2026-02-06 @ 2:04 PM
Study NCT ID:
NCT06070961
Status:
RECRUITING
Last Update Posted:
2025-06-29
First Post:
2023-10-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
Sponsor:
Fondazione Italiana Linfomi - ETS
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Follicular Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Lymphoma | View |
| None | Follicular | View |
| None | Immunochemotherapy | View |
| None | FL | View |
| None | Vaccine | View |
| None | COVID19 | View |
| None | SARS-COV-2 | View |
| None | Tetanus | View |
| None | Zoster | View |
| None | VZV | View |
| None | Rituximab | View |
| None | obinotuzumab | View |
| None | FOLL19 | View |
| None | FIL_FOLL19 | View |
| None | diphtheria | View |
| None | Maintenance | View |
| None | Humoral | View |
| None | Cellular | View |
| None | Immunity | View |
| None | Induction | View |